84% of NET patients
lack information
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
Latest News
Animations Describe Pheochromocytoma and Paraganglioma
The Pheo Para Alliance released two video animations explaining the basics of pheochromocytoma and paraganglioma. Watch and share to help raise awareness about these rare genetic neuroendocrine tumors. What is Pheo? What is Para?
CCF Releases Video on Lung Neuroendocrine Tumors and DIPNECH
The Carcinoid Cancer Foundation’s newest video is on lung neuroendocrine tumors and DIPNECH, featuring NET expert Dr. Robert Ramirez, oncology nurse navigator Pamela Ryan, and NET patient Paige McMurray. What are the symptoms? How are lung NET patients diagnosed,...
NETRF Accelerates Research into Treatments for Neuroendocrine Cancer with $2.62 Million in Awards
The Neuroendocrine Tumor Research Foundation (NETRF) announced $2.62 million in neuroendocrine tumor (NET) grants to advance research aimed at finding new and innovative treatments for this uncommon cancer. NETRF made the awards to nine investigators dedicated to...